These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27041002)

  • 1. Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
    Ngui NK; French J; Kilby CJ; Pathmanathan N; Elder EE
    J Surg Oncol; 2016 Jun; 113(7):726-31. PubMed ID: 27041002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients.
    Casabona F; Bogliolo S; Valenzano Menada M; Sala P; Villa G; Ferrero S
    Ann Surg Oncol; 2009 Sep; 16(9):2459-63. PubMed ID: 19506954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.
    Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS
    Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy?
    Tummel E; Ochoa D; Korourian S; Betzold R; Adkins L; McCarthy M; Hung S; Kalkwarf K; Gallagher K; Lee JY; Klimberg VS
    Ann Surg; 2017 May; 265(5):987-992. PubMed ID: 27163955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary reverse mapping: five-year experience.
    Ochoa D; Korourian S; Boneti C; Adkins L; Badgwell B; Klimberg VS
    Surgery; 2014 Nov; 156(5):1261-8. PubMed ID: 25444319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
    Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
    J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary reverse mapping (ARM) in clinically node positive breast cancer patients.
    Beek MA; Gobardhan PD; Klompenhouwer EG; Rutten HJ; Voogd AC; Luiten EJ
    Eur J Surg Oncol; 2015 Jan; 41(1):59-63. PubMed ID: 25468747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Study to Assess the Feasibility of Axillary Reverse Mapping and Evaluate Its Effect on Preventing Lymphedema in Breast Cancer Patients.
    Yue T; Zhuang D; Zhou P; Zheng L; Fan Z; Zhu J; Hou L; Yu F; Dong X; Xiao L; He Q
    Clin Breast Cancer; 2015 Aug; 15(4):301-6. PubMed ID: 25776198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.
    Nos C; Clough KB; Bonnier P; Lasry S; Le Bouedec G; Flipo B; Classe JM; Missana MC; Doridot V; Giard S; Charitansky H; Charles-Nelson A; Bats AS; Ngo C
    Eur J Surg Oncol; 2016 Dec; 42(12):1827-1833. PubMed ID: 27769634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients.
    Ikeda K; Ogawa Y; Komatsu H; Mori Y; Ishikawa A; Nakajima T; Oohira G; Tokunaga S; Fukushima H; Inoue T
    World J Surg Oncol; 2012 Nov; 10():233. PubMed ID: 23116152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary reverse mapping: Is it feasible in locally advanced breast cancer patients?
    Khandelwal R; Poovamma CU; Shilpy C; Prema M; Anthony P
    Breast Dis; 2014 Jan; 34(4):151-5. PubMed ID: 24934169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of sentinel node biopsy in male breast cancer.
    Maráz R; Boross G; Pap-Szekeres J; Markó L; Rajtár M; Ambrózay É; Bori R; Cserni G
    Breast Cancer; 2016 Jan; 23(1):85-91. PubMed ID: 24794951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary reverse mapping in breast cancer: a Canadian experience.
    Kuusk U; Seyednejad N; McKevitt EC; Dingee CK; Wiseman SM
    J Surg Oncol; 2014 Dec; 110(7):791-5. PubMed ID: 25053441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
    van la Parra RF; de Roos WK; Contant CM; Bavelaar-Croon CD; Barneveld PC; Bosscha K
    Eur J Surg Oncol; 2014 Oct; 40(10):1250-5. PubMed ID: 24685336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
    Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
    Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is axillary reverse mapping feasible in breast cancer patients?
    Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
    Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.
    Ponzone R; Cont NT; Maggiorotto F; Cassina E; Mininanni P; Biglia N; Sismondi P
    J Clin Oncol; 2009 Nov; 27(33):5547-51. PubMed ID: 19826123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.